Grifols SA (GRFS)
7.415
+0.06
(+0.88%)
USD |
NASDAQ |
Sep 28, 16:00
7.415
0.00 (0.00%)
After-Hours: 17:28
Grifols Cash from Operations (Annual) : 1.182B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.182B |
| December 31, 2024 | 975.87M |
| December 31, 2023 | 236.43M |
| December 31, 2022 | -0.1576M |
| December 31, 2021 | 719.14M |
| December 31, 2020 | 1.277B |
| December 31, 2019 | 641.78M |
| December 31, 2018 | 873.59M |
| December 31, 2017 | 949.43M |
| December 31, 2016 | 612.03M |
| December 31, 2015 | 829.23M |
| Date | Value |
|---|---|
| December 31, 2014 | 1.298B |
| December 31, 2013 | 785.96M |
| December 31, 2012 | 651.38M |
| December 31, 2011 | 306.28M |
| December 31, 2010 | 137.95M |
| December 31, 2009 | 122.61M |
| December 31, 2008 | 107.41M |
| December 31, 2007 | 121.34M |
| December 31, 2006 | 61.60M |
| December 31, 2005 | 148.71M |
| December 31, 2004 | 19.77M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Evaxion AS | -6.645M |
| argenx SE | 850.49M |
| Autolus Therapeutics Plc | -284.23M |
| Akari Therapeutics Plc | -10.59M |
| Pharma Mar SA | 59.96M |